Buccal Cavity Devices Market Report 2025

The buccal cavity devices market size has grown strongly in recent years. It will grow from $2.26 billion in 2024 to $2.47 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to oral drug delivery advancements, treatment of chronic conditions, patient compliance and convenience, pediatric and geriatric applications, localized drug delivery.

The buccal cavity devices market size is expected to see rapid growth in the next few years. It will grow to $3.66 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to expanding therapeutic applications, focus on precision medicine, rise in geriatric population, pediatric medication delivery, patient preference for non-invasive options. Major trends in the forecast period include innovations in mucoadhesive technologies, biodegradable and biocompatible materials, regulatory compliance and standardization, personalized medicine approaches, collaborations and partnerships.

Anticipated escalation in dental disorders is poised to propel the expansion of the buccal cavity devices market. This encompassing term refers to various oral health conditions affecting teeth, gums, and the buccal cavity. The significance of buccal cavity devices in dentistry lies in their role in capturing direct optical impressions and detecting oral health anomalies. The National Health Service's 2022-23 Annual Report from England substantiates this trend, reporting a notable increase in dental disorder treatments from 26.4 million in 2021 to 32.5 million in 2023, marking a substantial 23.2% surge. The upsurge in dental disorders underscores the driving force behind the growth trajectory of the buccal cavity devices market.

The increasing geriatric population is expected to drive the growth of the buccal cavity devices market in the future. The geriatric population, often defined as individuals aged 65 and older, is more vulnerable to oral diseases, including periodontal disease, dental caries, and oral cancer, which may necessitate specialized treatment options. Buccal cavity devices are particularly beneficial for the elderly, as they provide targeted drug delivery, shorten treatment time, and enhance patient comfort, making them an appealing choice for geriatric patients. For instance, in July 2024, the Office of National Statistics, a UK-based producer of official statistics, reported that in 2022, approximately 12.7 million individuals aged 65 and over resided in the UK, representing 19% of the total population. Projections indicate that by 2072, this number could rise to 22.1 million, accounting for 27% of the population. Therefore, the growing geriatric population is fueling the growth of the buccal cavity devices market.

Technological evolution stands as a pivotal trend shaping the landscape of buccal cavity devices. Leading entities within this sector are focused on developing advanced products to fortify their market standing. A notable example includes 3Shape, a Denmark-based digital dental solutions provider, launching TRIOS 5 Wireless in September 2022. This state-of-the-art intraoral scanner, equipped with Scan Assist intelligent alignment technology, ensures seamless and expedited intraoral scanning. Enhanced with an LED ring and tactile feedback, TRIOS 5 Wireless streamlines the scanning process, minimizing misalignments and distortions in 3D models. This emphasis on technological innovation reflects companies' strategic pursuit to deliver enhanced products within the buccal cavity devices market.

Strategic collaborations amongst key players in the buccal cavity devices sector are pivotal for driving market expansion and profitability. These partnerships are instrumental in developing and commercializing innovative solutions catering to diverse oral health issues. For instance, in March 2023, EVERSANA, a US-based life sciences service provider, partnered with ChemoMouthpiece LLC, an oncology supportive care company, to facilitate the launch and commercialization of the Chemo Mouthpiece. This buccal cavity device offers oral cryotherapy for chemotherapy-induced oral mucositis. EVERSANA's comprehensive suite of services, encompassing market access, regulatory compliance, patient services, data analytics, and distribution solutions, underscores the pivotal role of strategic collaborations in bringing specialized buccal cavity devices to market and addressing critical healthcare needs.

In December 2022, Alleima Ltd., a Sweden-based manufacturer of high-value-added products, acquired Endosmart Gesellschaft für Medizintechnik GmbH for an undisclosed amount. The acquisition of Endosmart strengthens and expands Alleima's position in the medical segment and product portfolio offerings. Endosmart Gesellschaft für Medizintechnik GmbH is a Germany-based manufacturer of medical devices and components, including dental cavity and intraoral cameras.

Major companies operating in the buccal cavity devices market include ACTEON Group Ltd., Align Technology Inc., Carestream Dental LLC, Cyber Medical Imaging, Inc., Denterprise International Inc., DENTSPLY SIRONA Inc., Detection Technology Plc, Envista Holdings Corporation, FONA Dental s.r.o., Hamamatsu Corporation, Midmark Corporation, Planmeca Group, The Yoshida Dental Mfg. Co. In., Trixell S.A.S, GlaxoSmithKline PLC, Johnson & Johnson, Novartis AG, AstraZeneca PLC, Merck & Co., Cigna, J. MORITA CORP., Varex Imaging Corporation, Alleima Ltd., Endosmart Gesellschaft für Medizintechnik GmbH, ChemoMouthpiece LLC, EVERSANA, Dentsply Sirona Inc., Carestream Health Inc., Cyber Medical Imaging Inc., Detection Technology PLC.

North America was the largest region in the buccal cavity devices market in 2024. The regions covered in the buccal cavity devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the buccal cavity devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Devices designed for the buccal cavity are specialized tools crucial in examining, diagnosing, treating, or preventing oral cavity conditions. They are tailored for use within the mouth, offering detailed imaging of teeth and aiding in identifying potential dental and jawbone issues.

These devices encompass various product types, including intraoral scanners, intraoral x-ray tubing, intraoral cameras, and others. Intraoral scanners, electronic devices capturing digital scans of intraoral structures, serve diverse purposes such as diagnostics, therapeutics, and more. These devices find application across dental clinics, hospitals, and similar medical settings.

The buccal cavity devices market research report is one of a series of new reports that provides buccal cavity devices market statistics, including buccal cavity devices industry global market size, regional shares, competitors with a buccal cavity devices market share, detailed buccal cavity devices market segments, market trends and opportunities, and any further data you may need to thrive in the buccal cavity devices industry. This buccal cavity devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The buccal cavity devices market consists of sales of dental mirrors, probes and explorers, dental forceps. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.